US 9138479
Formulations for the treatment of diabetes
granted A61KA61K38/22A61K38/28
Quick answer
US patent 9138479 (Formulations for the treatment of diabetes) held by XERIS PHARMACEUTICALS, INC. expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XERIS PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K38/22, A61K38/28, A61K47/20, A61K9/0019